Alnylam Pharma (ALNY) Reports In-Line Q3 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street futures edge lower after AI selloff, telecom slide
- Brent crude hits more than five-month high on concern over Middle East escalation
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- UBS sees dip buyers stepping in to support gold at this level
| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 227.28 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $227.28 | 52 Week High | $109.10 | |||
| Open | $227.28 | 52 Week Low | $31.38 | |||
| Day High | $227.28 | P/E | N/A | |||
| Day Low | $227.28 | EPS | $-1.45 | |||
| Volume | 1,723 | |||||
